Case series: propranolol liquid in the treatment of tachyarrhythmias in neonates and infants: potential for errors.
Propranolol
antiarrhythmic
infant
prescribing
Journal
Cardiology in the young
ISSN: 1467-1107
Titre abrégé: Cardiol Young
Pays: England
ID NLM: 9200019
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
pubmed:
30
6
2022
medline:
17
3
2023
entrez:
29
6
2022
Statut:
ppublish
Résumé
Oral propranolol therapy is commonly used for the prevention of tachyarrhythmias in infancy and childhood. Propranolol is commercially produced in four concentrations allowing varying volumes to be administered. However, quite often an alternative strength of propranolol liquid is issued without clear change in instructions or warning. This may lead to parents inadvertently administering the wrong dose.
Identifiants
pubmed: 35766178
pii: S1047951122001986
doi: 10.1017/S1047951122001986
doi:
Substances chimiques
Propranolol
9Y8NXQ24VQ
Adrenergic beta-Antagonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM